Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase NA 16Phase 4 16Phase 3 9Phase EARLY_PHASE1 4Phase 2/3 3Phase 1 3Phase 1/2 2

Status

Completed 21Terminated 6Recruiting 6Withdrawn 4Active not recruiting 4Unknown 3Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 1

Conditions

Polycystic Ovary Syndrome 1Ketosis 1Insulin Resistance 1Glioma 1Glioblastoma 1Drug-drug Interaction,SHR3680 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 49fludarabine 37Injections 32Gemcitabine 24Paclitaxel 23Cisplatin 21pembrolizumab 19Radiotherapy 19toripalimab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 13Nivolumab 12Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Cetuximab 11Bevacizumab 10Irinotecan 9Immunotherapy, Adoptive 9Drug Therapy 9Etoposide 8sintilimab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7Leucovorin 7Ipilimumab 7Indium 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Metformin × Clear all
NCT02244567 2021-02-02

U-C OC IN PCOS

Beni-Suef University

Phase 1 Unknown
100 enrolled

Polycystic Ovary Syndrome

NCT04621669 2020-11-09

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown
18 enrolled

Drug-drug Interaction,SHR3680

NCT02149459 2017-10-27

SMC 0712-13

Sheba Medical Center

Phase 1 Unknown
18 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡